Prior infection does not improve survival against the amphibian disease chytridiomycosis by Cashins, Scott D. et al.
Prior Infection Does Not Improve Survival against the
Amphibian Disease Chytridiomycosis
Scott D. Cashins1*, Laura F. Grogan1, Michael McFadden2, David Hunter3, Peter S. Harlow2, Lee Berger1,
Lee F. Skerratt1
1 James Cook University, School of Public Health, Tropical Medicine and Rehabilitation Sciences, Townsville, Queensland, Australia, 2 Taronga Conservation Society
Australia, Herpetofauna Division, Mosman, New South Wales, Australia, 3New South Wales Office of Environment and Heritage, Biodiversity Conservation Section,
Queanbeyan, Australia
Abstract
Many amphibians have declined globally due to introduction of the pathogenic fungus Batrachochytrium dendrobatidis (Bd).
Hundreds of species, many in well-protected habitats, remain as small populations at risk of extinction. Currently the only
proven conservation strategy is to maintain species in captivity to be reintroduced at a later date. However, methods to
abate the disease in the wild are urgently needed so that reintroduced and wild animals can survive in the presence of Bd.
Vaccination has been widely suggested as a potential strategy to improve survival. We used captive-bred offspring of
critically endangered booroolong frogs (Litoria booroolongensis) to test if vaccination in the form of prior infection improves
survival following re exposure. We infected frogs with a local Bd isolate, cleared infection after 30 days (d) using itraconazole
just prior to the onset of clinical signs, and then re-exposed animals to Bd at 110 d. We found prior exposure had no effect
on survival or infection intensities, clearly showing that real infections do not stimulate a protective adaptive immune
response in this species. This result supports recent studies suggesting Bd may evade or suppress host immune functions.
Our results suggest vaccination is unlikely to be useful in mitigating chytridiomycosis. However, survival of some individuals
from all experimental groups indicates existence of protective innate immunity. Understanding and promoting this innate
resistance holds potential for enabling species recovery.
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Introduction
Over the past 40 years, amphibians across the globe have
rapidly declined and are now the most threatened class of
vertebrates, with at least one third of all species threatened with
extinction [1]. Apart from habitat loss, the main cause of these
declines is the emergence of the disease chytridiomycosis caused by
the pathogenic fungus, Batrachochytrium dendrobatidis (Bd; [2–3]).
Multiple lines of evidence indicate Bd has recently spread
worldwide from an unknown origin via human-mediated transport
into naive populations [4–7]. As a result, hundreds of susceptible
species are feared extinct or have been reduced to small and
vulnerable populations, often in well-protected and intact habitat.
Conservation biology aims to maintain or restore biodiversity,
often by protecting the overall health of ecosystems. However,
when specific threats to biodiversity occur in otherwise healthy
ecosystems (e.g. chytridiomycosis), it is prudent to abate these
threats directly [8]. Unfortunately, few tools are currently available
to abate chytridiomycosis in the wild [9], limiting the options of
wildlife managers to the captive management of species to prevent
extinction [10,11]. Where reintroduction programs have been
attempted most struggle or completely fail due to the ongoing
impact of chytridiomycosis [12,13]. This is a familiar issue facing
animal relocations, and reintroduction efforts in other taxa have
been unsuccessful due to the failure to address the processes
causing decline [14,15].
A vaccination that provides protective immunity against Bd or
reduces infectious burdens to a sublethal level could be used to
improve survival rates in reintroduced frogs and important wild
populations. Intensive vaccination could buy time for the evolution
of resistance or tolerance to infection by maintaining population
size and genetic diversity in the face of extirpation due to small
population bottlenecks [9,16]. Manipulating adaptive immunity
through vaccination or inoculation has been successful in
combating numerous diseases of domestic and wild animals as
well as humans. Well-known examples of vaccination in wildlife
include the control of sylvatic plague in black-footed ferrets [17]
and the control of rabies in mammals [18]. It has been suggested
that similar methods could be used to help control chytridiomy-
cosis. Although there are no fungal vaccines yet approved for any
animal, antibodies to various human fungal pathogens can be
protective and promising trials are underway for Candida and
Cryptococcus [19].
Amphibians, like all vertebrates, have a complex immune
system, consisting of both innate and adaptive components [20].
Recent evidence suggests adaptive responses may be important in
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fighting chytridiomycosis [21,22]. The African clawed frog
(Xenopus laevis) produced a higher concentration of mucosal
antibodies following exposure to Bd, however, it remains
unknown, whether this is effective in controlling infection and
improving survival and whether the response is heightened with
re-exposure. Experimental elimination of splenic lymphocytes (via
X-irradiation) of X. laevis resulted in greater infection intensities
and decreased weight suggesting that the adaptive immune system
may be important in controlling infection [23]. However,
subcutaneous injection of heat (host: X. laevis) or formalin-killed
(host: mountain yellow-legged frog; Rana muscosa) Bd did not
control infection or improve survival even though it induced a
systemic response in X. laevis resulting in circulating antibodies to
Bd [23,24].
Route of exposure and the nature of the antigen may be
important in inducing an effective adaptive response to chytridio-
mycosis. Subcutaneous or intraperitoneal injection less effectively
stimulate epidermal antigen presenting cells leading potentially to
a systemic immune response, rather than targeting the skin where
Bd infection naturally occurs [16]. Stimulating this epidermal
response may require topical exposure to live Bd to stimulate the
normal route of infection and ensure appropriate epitopes are
available to be recognized by the immune system [25]. Alterna-
tively, if Bd is able to evade [26] or suppress [27,28] the host
immune response then a prior infection will likely have little effect
on survival and development of an effective vaccination strategy
will be more complex. Although exposure to a live pathogen is a
crude form of vaccination, it is inexpensive and could be applied
immediately to species urgently requiring interventions to survive.
In this study we test the hypothesis that a real infection followed by
treatment to clear Bd will provide immunity and increase survival
following a second exposure. We investigate this in captive-bred
individuals of the critically endangered booroolong frog (Litoria
booroolongensis), which is thought to have declined due to
chytridiomycosis in areas of New South Wales (NSW), Australia
[29].
Materials and Methods
Ethics Statement
The research protocols were approved by the James Cook
University (A1408) and Taronga Conservation Society (5a/07/09)
animal ethics committees.
Captive Husbandry
To ensure all animals involved in this study had no prior
exposure to Bd, we raised all experimental frogs from the captively
bred spawn of confirmed Bd negative wild collected adults. Mature
L. booroolongensis were collected from a 3 km section of the Retreat
River in Abercrombie River National Park (34u 79 18.130 S, 149u
389 4.980 E) on the central west slopes of NSW with the permission
of the New South Wales Office of Environment and Heritage. Egg
masses were raised in gently aerated 32 L plastic tubs. At 14 d
post-hatching, five groups of 40 tadpoles from each spawn were
transferred to individual trays, flushed every 4 hr with filtered
water. Water temperature was 20–21˚C and each tray had one
UVB emitting fluorescent tube and one daylight fluorescent tube
set to a 10:14 h light:dark cycle. We fed tadpoles frozen endive
and a fish food flake mix ad libitum. At metamorphosis groups of 20
individuals were transferred to 20 L plastic aquariums flushed with
fresh water daily. Frogs were fed calcium and multivitamin dusted
crickets twice and once per week respectively and kept on a
12:12 h light:dark cycle in addition to natural light through
windows until they were 6 mo old when we randomly assigned
each frog to a treatment group, waited 7 d to allow acclimation,
and began the experiment.
Culture of Batrachochytrium dendrobatidis
We isolated Bd from an adult L. booroolongensis captured along
the same stretch of the Retreat River in Abercrombie National
Park where the founding captive colony animals were sourced
(AbercrombieNP-L.booroolongensis-09-LB-P7) with the permis-
sion of the New South Wales Office of Environment and Heritage.
The culture was maintained at 20˚C on TGHL agar plates [3]. To
harvest zoospores for exposures, we flooded plates with 10 ml
dilute salts solution (in mMol: KH2PO4 1.0, CaCl2.H2O 0.2,
MgCl2.2H2O 0.1) for 20 minutes. Three separate counts were
made with a haemocytometer and averaged, and the stock
zoospore solution diluted with the dilute salts solution to 150,000
zoospores/ml.
Diagnostic Polymerase Chain Reaction (PCR)
Throughout the experiment, frogs were swabbed with sterile,
dry cotton tipped swabs (Medical Wire & Equipment Co MW100-
100), and analysed following established protocols with a
quantitative PCR TaqMan Assay that estimates the number of
Bd zoospores present on the swab [30–32]. PCR reactions were
run in triplicate and we considered a sample positive if at least one
well returned a positive reaction to maximize sensitivity and
maintain specificity [33]. Following swabbing, the mass (0.1 g) of
each frog was recorded.
Experimental Design
We established four experimental groups to investigate the effect
of vaccination via pre-infection (Fig. 1). Group 1 (inoculated) was
exposed to and infected with Bd, then cleared of infection with
itraconazole and re-exposed to Bd 80 d post-treatment. Group 2
(treated) controlled for any residual antifungal effects of itracon-
azole and were not initially exposed to Bd, but were treated with
itraconazole, then exposed to Bd for the first time. Group 3 (naı¨ve)
were not exposed, not treated and then exposed to Bd for the first
time. Group 4 (control) were never exposed to Bd nor treated with
itraconazole.
Initial Exposure
We individually exposed 59 frogs to 750,000 zoospores in 5 ml
dilute salts solution (sufficient to immerse the ventral surface of the
frog) in 50 ml polyethylene tubs for 3 hrs on three consecutive
days. At the end of each 3 hr exposure period and for 4 d
following the last exposure, we transferred each frog and their
inoculation broth to a 1000 ml polyethylene box containing 10 ml
water (enough to cover the bottom of the container) that was
replaced daily. We treated unexposed frogs similarly, but sham-
exposed with only dilute salts solution. After 7 d, frogs were moved
from the small exposure boxes to individual 10 L plastic
aquariums fitted with a false bottom (plastic egg crate wrapped
in shade cloth) for drainage, a hide, and a 250 ml polyethylene tub
containing water. Room temperature was maintained at 2062 uC,
the same temperature at which the Bd cultures were grown, and
within the temperature range when L. booroolongensis are most
active in the wild. Sprinklers sprayed the inside of each aquarium
with water for 1 min every 4 hr and water tubs were replenished
daily. This setup maintained high humidity, but allowed frogs the
choice to avoid standing water and partially dry. Frogs were
swabbed at 0, 2, and 3 wks post-exposure. At 3 wk, 43/59 (73%)
frogs were infected. One frog died with clinical signs of
chytridiomycosis between weeks 3 and 4. We removed the 16
Inoculation Fails to Protect against Bd
PLOS ONE | www.plosone.org 2 February 2013 | Volume 8 | Issue 2 | e56747
exposed frogs that did not become infected from the experiment as
we were interested in the protective effect of a prior active
infection, not just prior exposure, on subsequent exposure to the
pathogen.
Antifungal Treatment
At 4 wk, we began treatment to clear infection. Studies in the
model amphibian X. laevis indicate T-cell mediated responses
begin approximately 14 d post exposure [16]. Therefore 4 wks
was considered sufficient time for priming an adaptive response via
clonal expansion. We placed all 43 infected frogs (inoculated) and
11 unexposed frogs (treated) in individual 50 ml polyethylene tubs
and poured 5 ml (enough to immerse the ventrum) 0.01%
itraconazole (Sporanox) over the dorsal surface [34]. Frogs were
kept in the treatment solution for 5 min daily for 7 d, before being
returned to their aquaria. All frogs survived and cleared infection
as indicated by three negative PCR results at 2, 5 and 11 wks
following the end of treatment.
Second Exposure
At 80 d post-treatment (109 d post 1st exposure) we exposed
frogs in the inoculated, treated and naive groups to 750,000
zoospores in dilute salts solution daily for 3 d as described
previously. The control group was sham-exposed to dilute salts
solution alone. We swabbed all frogs at 2, 3, 5 and 9 wk post-
exposure and at death. At 70 d following the second exposure
(179 d post 1st exposure) all surviving frogs were euthanized with
an overdose of MS-222 (2 g/L in water).
Results
Prior Bd infection or prior treatment with itraconazole had no
significant effect (a= 0.05, 2-sided Fisher’s exact test) on survival
(p = 1.0), infection status (p = 0.058), proportion of infected
individuals that cleared infection (p = 0.924) or the proportion of
survivors that were infected at the end of the experiment
(p = 0.487). Approximately half of the infected frogs in each
treatment group successfully cleared infection and approximately
85% of frogs in each treatment group survived (Table 1).
A Kaplan-Meier survival curve using days survived as the
response variable and censoring individuals that survived until the
end of the experiment revealed no significant difference among
groups using either the log-rank or Wilcoxon tests (Fig. 2, p.0.22
for both tests), and a Cox proportional hazards regression showed
that neither experimental group, sex nor mass had a detectable
effect on survival. All experimental groups continued to feed
normally and increased in body mass following the second
exposure. A one-way analysis of variance (ANOVA) revealed no
significant difference in change of body mass among treatments
between the second exposure and the end of the experiment
(ANOVA; df = 3, F = 2.34, p = 0.083) indicating lack of a strong
sublethal effect on body condition.
All frogs that died during the experiment were infected (Table 1)
and their mean intensity of infection was significantly higher at
each sampling period than in infected frogs surviving to the end of
the experiment (Fig. 3). In infected survivors, mean infection
intensity increased rapidly within the first 2 wks following the
second exposure and then plateaued (Fig. 3). Possible differences in
infection intensity over time (beginning 2 wks post re-exposure)
among treatments were analysed with a factorial, repeated
measures ANOVA using Log10 transformed PCR results of frogs
that were infected at least once during the experiment but did not
die. Degrees of freedom were corrected using Greenhouse-Geisser
estimates as the data violated the assumption of sphericity. Neither
the interaction of treatment and time (F(4.5,67.7) = 1.9, p = 0.113)
nor time (F(3,67.7) = 0.82, p = 0.457) or treatment alone
(F(2,30) = 2.76, p = 0.079) had a significant effect on intensity of
infection (Fig. 3).
Discussion
We found no evidence for increased protective immunity
following infection with Batrachochytrium dendrobatidis. Prior expo-
sure and treatment of Bd has been widely promoted as a
straightforward and inexpensive, but untested vaccination method
to improve the survival of susceptible species [21,25,35]. Our
results show, however, that prior infection and treatment is
unlikely to be an effective management strategy for L. booroolon-
gensis, and possibly other species threatened by chytridiomycosis
worldwide. While the relatively high survival and moderate cure
Figure 1. Flow chart of experimental treatment groups.
doi:10.1371/journal.pone.0056747.g001
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rates indicate many of the frogs in this study had some form of
resistance, the inability of a prior infection to increase protective
immunity is striking, and a major blow to conservation efforts.
Although we found a near significant effect of treatment on
prevalence (Fisher’s exact test: p = 0.058) and intensity of infection
(Repeated Measures ANOVA: F(2,30) = 2.76, p = 0.079), the
direction of the effect for both results was opposite what would
be expected with a successful vaccination. If prior infection
provides a benefit, the ‘inoculated’ frogs should have lower
prevalence and mean intensity of infection than the other
experimental groups. Instead, prevalence was similar between
the ‘inoculated’ and ‘naı¨ve’ groups but higher in the ‘treated’
group (Table 1), and intensity of infection was similar across all
treatments and time periods, but lower in the ‘naı¨ve’ group 3 wk
post re-exposure (Fig. 3). Neither of these unexpected and
marginally significant results has a clear biological explanation,
thus we decline from further speculation about their cause.
It remains unclear why prior exposure was ineffective against
Bd. It is possible that Bd avoids and down regulates the adaptive
immune response. Fungal diseases of amphibians typically incite
strong inflammatory reactions observed microscopically [36], but
this response is not observed in skin infected with Bd [37]. Berger
et al. (1999) [38] suggested that sporangia (the reproductive phase
of Bd) may effectively evade recognition by the host due to their
location inside cells of the superficial epidermis. Intracellular and
epithelial sites of infection are both features in common with other
fungi that can hide from phagocytes [26]. In addition to evading
the amphibian immune system, recent evidence suggests Bd may
also actively suppress an immune response. In the clawed frog
Silurana tropicalis, infection results in down regulation of genes
associated with toll-like receptors (which could assist pathogen
recognition), complement pathways, and B and T-lymphocytes
[27,28]. This is possibly due to the release of soluble factors
inhibitory to B and T-cells as demonstrated by in-vitro lymphocyte
proliferation assays (J. Ramsey et al., unpublished in Rollins-Smith
et al. 2011 [35]). General mechanisms of fungal evasion and
suppression include shielding surface antigens, inducing anti
inflammatory cytokines, decreasing inflammatory cytokines and
phenotypic switching. The ability to evade or inhibit the immune
system is a feature of other highly virulent diseases that, like
chytridiomycosis, can kill previously healthy hosts and are difficult
to control, e.g. malaria.
Although potential remains to develop a targeted Bd vaccine
that overcomes possible evasion and inhibition of the adaptive
immune response, it will likely be too expensive and lengthy an
exercise to help critically threatened amphibian populations in the
near future. For example, it has taken two decades and $300
million in investment to develop an effective malaria vaccine that
cuts the risk of infection in infants by 56% [39,40].
Despite the current unsuitability of prior exposure as a
vaccination strategy, our findings contribute to a broader
understanding of the ecology of chytridiomycosis. The lack of an
observable adaptive response to Bd (absence of an ‘immune’ state)
helps explain the dynamics observed in the field, such as the
regular re-infection of individuals [41,42] and annual seasonal
outbreaks [3,7,36,43–44].
Although we found no evidence that prior infection elicits an
effective adaptive immune response, the majority of booroolong
frogs in this study clearly had some form of resistance. Despite
inoculation with 750,000 zoospores for 3 d (a dose higher than
would be experienced in the wild), 38% of frogs never developed a
detectable infection. Of the 62% that were infected, mortality rates
were relatively low (25%) across experimental groups, and in
surviving frogs infection intensity peaked 3 wk post exposure
before stabilising or declining for all treatments. Overall, 50% of
all infected frogs successfully cleared infection, 25% maintained a
sublethal infection until the end of the experiment and 25% were
unable to control pathogen replication and died with elevated
zoospore burdens.
Table 1. Infection, clearance and survival rates of each treatment group (excluding unexposed controls) following exposure to
Batrachochytrium dendrobatidis (Bd).
Inoculated Treated Naı¨ve
Fisher’s exact test (p-
value)
Bd infection rate (overall) 20/32 (63%) 10/11 (91%) 14/28 (50%) 0.058
Bd clearance rate 11/20 (55%) 5/10 (50%) 6/14 (43%) 0.924
Survival rate 27/32 (84%) 9/11 (82%) 24/28 (86%) 1.000
Bd infection rate (survivors) 4/27 (15%) 3/9 (33%) 4/24 (17%) 0.487
Bd infection rate (non survivors) 5/5 (100%) 2/2 (100%) 4/4 (100%)
‘‘Inoculated’’ frogs were previously exposed and infected with Bd and cleared of infection with itraconazole prior to exposure, ‘‘Treated’’ frogs were not initially exposed
to Bd but were treated with itraconazole prior to exposure, ‘‘Naı¨ve’’ frogs were not exposed nor treated prior to exposure.
doi:10.1371/journal.pone.0056747.t001
Figure 2. Kaplan-Meier curve depicting the proportion of frogs
surviving in each treatment group over the days post Bd
exposure. ‘‘Inoculated’’ frogs were previously exposed and infected
with Bd and cleared of infection with itraconazole prior to exposure.
‘‘Treated’’ frogs were not initially exposed to Bd but were treated with
itraconazole prior to exposure. ‘‘Naı¨ve’’ frogs were not exposed nor
treated prior to exposure. ‘‘Control’’ frogs were never exposed nor
treated at any point during the experiment.
doi:10.1371/journal.pone.0056747.g002
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Mortality from chytridiomycosis in the field has been reported
to occur once the infectious burden increases above a mean
threshold of 104–105 zoospore equivalents [42,44]. A similar fatal
threshold was found in this study and individuals able to eliminate
or maintain infection below 104–105 zoospores survived. Frogs
were housed in optimal conditions for the pathogen (20uC and
high humidity [45]) throughout the experiment, eliminating the
possibility of experimental conditions alone causing clearance of
infection. However, frogs were given the freedom to avoid direct
contact with standing water (as would occur in the wild for this
species) which could help limit pathogen proliferation and re-
infection.
As observed resistance was unrelated to prior exposure, innate
immune responses are likely responsible for limiting pathogen
replication below the threshold. Interestingly, this resistance was
not apparent when we exposed booroolong frogs to the same Bd
Figure 3. Mean intensity of Batrachochytrium dendrobatidis infection over time. a) Initial exposure of and treatment of ‘‘inoculated’’ frogs and
treatment of ‘‘treated’’ frogs. b) Second exposure of all frogs except unexposed controls (controls not shown). Frogs that died of chytridiomycosis are
from across treatment groups. All other lines depict only frogs that survived.
doi:10.1371/journal.pone.0056747.g003
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zoospore dose in groups of 10 (750,000 zsps/10 frogs) and 100% of
frogs died due to chytridiomycosis (compared with 100% survival
in unexposed controls; S. Cashins unpublished data), suggesting
defences are overwhelmed with constant re-exposure from nearby
hosts. This supports field studies identifying population density as
an important predictor of Bd infection intensity and impact [42,44]
and may help explain why L. booroolongensis have declined in the
wild despite their moderate susceptibility in captivity.
Vaccination via live infection has been a commonly proposed
solution to mitigate the impact of chytridiomycosis on amphibian
biodiversity [9]. Although our study did not support this as an
effective strategy, a number of potential management solutions
remain which are aimed at either the pathogen or the host.
Pathogen-focused strategies involve intensive site management
such as the manipulation of water chemistry or natural chytrid
predators to reduce pathogen survival and density in the
environment [46,47]. These strategies hold the most promise at
select, discrete pond sites of high conservation value where
ongoing and intensive human involvement is available to maintain
conditions inhospitable for Bd.
Host-focused strategies seek to promote the factors responsible
for host persistence. Some species that suffered range contractions
due to Bd are now recolonising previously inhabited areas,
suggesting one or more of three possibilities: 1. resistance is
evolving naturally. 2. Bd is becoming less virulent and 3. lower
density populations are able to survive in areas were higher
population densities were extirpated [48,49]. Species at high risk of
extinction may thus be effectively managed if the underlying
mechanisms of host resistance, pathogen virulence and disease
dynamics are identified.
The potential for manipulating pathogen virulence has yet to be
explored and while limiting host-density may provide a short term
solution to species survival it is counterproductive to conservation
in the long-term. Increasing the reproductive fitness or distribution
of individuals with more robust innate immunity through head-
starting, translocation of survivors, or reintroduction programs
that select for resistance currently holds the most promise for long-
term mitigation of disease in species threatened with chytridio-
mycosis. Differences in susceptibility between and within species
have been described in this and other studies [50,51], and have
been correlated with individual aspects of innate immunity such as
antimicrobial peptides [52], MHC diversity [22] or competitive
skin bacteria [53]. However, Bd is an unusual pathogen (as the
only member of the Phylum Chytridiomycota to cause disease in
vertebrates and as a fatal cutaneous fungus) and so host immune
mechanisms may also be unusual and complementary. Studies
that adopt a broad, exploratory approach and investigate multiple
components of innate immunity through immunological, genetic
and post-genomic analyses are needed to begin identifying the
most important mechanisms of observed resistance.
Many endangered amphibian species threatened by chytridio-
mycosis exist as small populations that are unsustainable. We have
found that vaccination via pre-exposure with live Bd is unlikely to
be of assistance.
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